SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-21-000024
Filing Date
2021-07-29
Accepted
2021-07-29 16:05:10
Documents
13
Period of Report
2021-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20210729.htm   iXBRL 8-K 32963
2 EX-99.1 ex-991_q22021.htm EX-99.1 267889
  Complete submission text file 0000875320-21-000024.txt   461191

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20210729.xsd EX-101.SCH 1987
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20210729_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20210729_pre.xml EX-101.PRE 12593
6 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20210729_htm.xml XML 10593
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 211127374
SIC: 2834 Pharmaceutical Preparations